Earnings · China A-shares
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Class A (300357) earnings
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-23: net profit +13.46% year on year, +5.94% excluding one-off items. Wave Radar's earnings-quality score is 95 of 100 (Sound). The stock moved +8.87% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-23
- Period end
- 2026-09-30
- Net profit YoY
- +13.46%
- Excl. one-offs YoY
- +5.94%
- Net profit QoQ
- +88.75%
- Result
- Neutral
- Quality score
- 95
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +8.30% | — |
| 3 days | +8.87% | — |
| 7 days | +11.14% | — |
| 14 days | +12.94% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +4.29%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-24 | ¥391.29M | +13.46% | +5.94% | +6.64% | 0.75 | 14.07% | +8.87% | — | — |
| 2026 interim report | 2026-08-28 | ¥213.45M | +20.59% | +6.05% | +6.18% | 0.41 | 7.87% | -2.57% | -19.22% | -9.53% |
| 2026 Q1 report | 2026-04-24 | ¥119.23M | +60.38% | +21.36% | +10.67% | 0.23 | 4.45% | -0.27% | -17.08% | -17.50% |
| 2025 annual report | 2026-04-24 | ¥380.94M | +19.86% | +22.16% | +14.81% | 0.73 | 15.19% | -0.27% | -17.08% | -17.50% |
| 2025 Q3 report | 2025-10-24 | ¥344.87M | +26.67% | +28.92% | +16.86% | 0.66 | 13.80% | +11.25% | -2.93% | -2.70% |
| 2025 interim report | 2025-08-22 | ¥177.01M | +18.61% | +21.97% | +12.81% | 0.34 | 7.28% | +8.50% | +8.68% | +0.88% |
| 2025 Q1 report | 2025-04-19 | ¥74.34M | -3.71% | +1.48% | +5.65% | 0.14 | 3.11% | -0.05% | +4.87% | +1.92% |
| 2024 annual report | 2025-04-19 | ¥317.82M | +2.46% | +2.72% | +9.10% | 0.61 | 13.89% | -0.05% | +4.87% | +1.92% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.